Apogee Therapeutics Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Jun 2022 | — | — | $5.0M |
| Sep 2022 | — | — | $2.6M |
| Dec 2022 | — | — | $151.9M |
| Mar 2023 | — | — | $141.3M |
| Jun 2023 | — | — | $125.1M |
| Sep 2023 | — | — | $188.3M |
| Dec 2023 | — | — | $118.3M |
| Mar 2024 | — | — | $485.5M |
| Jun 2024 | — | — | $307.3M |
| Sep 2024 | — | — | $118.8M |
| Dec 2024 | — | — | $141.8M |
| Mar 2025 | — | — | $106.9M |
| Jun 2025 | — | — | $124.2M |
| Sep 2025 | — | — | $107.9M |
| Dec 2025 | — | — | $131.5M |
| Mar 2026 | — | — | $451.8M |
| Jun 2026 | — | — | $105.6M |